169 related articles for article (PubMed ID: 12457020)
1. Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology.
Bersani G; Orlandi V; Gherardelli S; Pancheri P
Psychopathology; 2002; 35(5):289-95. PubMed ID: 12457020
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.
Bersani G; Orlandi V; Kotzalidis GD; Pancheri P
Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):86-92. PubMed ID: 12111342
[TBL] [Abstract][Full Text] [Related]
3. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
[TBL] [Abstract][Full Text] [Related]
4. Influence of cannabis abuse on schizophrenic psychopathology.
Peralta V; Cuesta MJ
Acta Psychiatr Scand; 1992 Feb; 85(2):127-30. PubMed ID: 1543037
[TBL] [Abstract][Full Text] [Related]
5. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
Dubertret C; Bidard I; Adès J; Gorwood P
Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837
[TBL] [Abstract][Full Text] [Related]
6. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
[TBL] [Abstract][Full Text] [Related]
7. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
Hambrecht M; Häfner H
Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
[TBL] [Abstract][Full Text] [Related]
8. [Neurological soft signs in early onset schizophrenia].
Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
[TBL] [Abstract][Full Text] [Related]
9. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD).
Hollis C; Groom MJ; Das D; Calton T; Bates AT; Andrews HK; Jackson GM; Liddle PF
Schizophr Res; 2008 Oct; 105(1-3):216-23. PubMed ID: 18768298
[TBL] [Abstract][Full Text] [Related]
10. Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder.
Zhao Q; Ma YT; Lui SS; Liu WH; Xu T; Yu X; Tan SP; Wang ZR; Qu M; Wang Y; Huang J; Cheung EF; Dazzan P; Chan RC
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():72-8. PubMed ID: 23266480
[TBL] [Abstract][Full Text] [Related]
11. Cannabis use and schizophrenia.
Krebs MO; Goldberger C; Dervaux A
Am J Psychiatry; 2005 Feb; 162(2):401-2; author reply 402. PubMed ID: 15677615
[No Abstract] [Full Text] [Related]
12. [Cannabis and schizophrenia. From euphoria to psychosis].
Berger N
Rev Med Liege; 2004 Feb; 59(2):98-103. PubMed ID: 15112899
[TBL] [Abstract][Full Text] [Related]
13. Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia.
Dervaux A; Goldberger C; Gourion D; Bourdel MC; Laqueille X; Lôo H; Olié JP; Krebs MO
Schizophr Res; 2010 Nov; 123(2-3):278-80. PubMed ID: 20832995
[No Abstract] [Full Text] [Related]
14. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness.
Whitty P; Clarke M; McTigue O; Browne S; Gervin M; Kamali M; Lane A; Kinsella A; Waddington J; Larkin C; O'Callaghan E
Schizophr Res; 2006 Sep; 86(1-3):110-7. PubMed ID: 16765029
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
[TBL] [Abstract][Full Text] [Related]
16. Neurological soft signs in non-psychotic patients with cannabis dependence.
Dervaux A; Bourdel MC; Laqueille X; Krebs MO
Addict Biol; 2013 Mar; 18(2):214-21. PubMed ID: 21054691
[TBL] [Abstract][Full Text] [Related]
17. Cannabis use and schizophrenia.
Wade D
Am J Psychiatry; 2005 Feb; 162(2):401; author reply 402. PubMed ID: 15677616
[No Abstract] [Full Text] [Related]
18. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study.
van Dijk D; Koeter MW; Hijman R; Kahn RS; van den Brink W
Schizophr Res; 2012 May; 137(1-3):50-7. PubMed ID: 22313726
[TBL] [Abstract][Full Text] [Related]
19. Deficit of executive functions in schizophrenia: relationship to neurological soft signs and psychopathology.
Bersani G; Clemente R; Gherardelli S; Pancheri P
Psychopathology; 2004; 37(3):118-23. PubMed ID: 15153743
[TBL] [Abstract][Full Text] [Related]
20. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
